JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fouts, J. R.
Right arrow Articles by Brodie, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fouts, J. R.
Right arrow Articles by Brodie, B. B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 115, Issue 1, 68-73, 1955
Copyright © 1955 by American Society for Pharmacology and Experimental Therapeutics


INHIBITION OF DRUG METABOLIC PATHWAYS BY THE POTENTIATING AGENT, 2,4-DICHLORO-6-PHENYL-PHENOXYETHYL DIETHYLAMINE

J. R. Fouts 1 and Bernard B. Brodie 1

1 The Laboratory of Chemical Pharmacology, National Heart Institute, National Institutes of Health, Public Health Service, U. S. Department of Health, Education, and Welfare, Bethesda, Maryland

2, 4-Dichloro-6-phenylphenoxyethyl diethylamine HBr (Lilly 18947), in doses devoid of sedative activity, prolongs the hypnotic activity of hexobarbital in mice by inhibiting its rate of biotransformation.

Lilly 18947 inhibits enzyme systems present in liver microsomes which oxidize the sidechain of hexobarbital, dealkylate aminopyrine, deaminate amphetamine, cleave the ether linkage of codeine, hydroxylate acetanilide and conjugate morphine. These biochemical pathways are also blocked by beta-diethylaminoethyldi-phenyipropylacetate HCl (SKF 525-A) and diphenylpropylacetic acid (SKF acid).

It is probable that, despite their dissimilarity in structure, Lilly 18947 and the SKF compounds act by a similar mechanism.

Submitted on May 4, 1955







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1955 by the American Society for Pharmacology and Experimental Therapeutics.